Technology
BiVictriX secures US patent for flagship therapeutic asset
Cancer treatment developer BiVictriX Therapeutics has secured a significant patent from the United States Patent and Trademark Office (USPTO), it announced on Wednesday, for its flagship therapeutic asset, BVX001.
Pebble Beach revenue rises despite weaker order intake
Broadcasting and streaming software and technology specialist Pebble Beach Systems reported a first-half revenue boost of 9% on Wednesday, bringing the figure up to £5. 5m.
Tracsis describes robust full-year growth
Transport technology specialist Tracsis reported robust growth, as well as a strong financial position, in a full-year trading update on Wednesday.
XLMedia inks partnership with North Carolina's WRAL
Global digital media giant XLMedia announced a significant strategic partnership with Capitol Broadcasting Company on Tuesday, which owns North Carolina-based news brand WRAL.
Plexus shares jump on expansion of major contract
Oil and gas engineering services company Plexus Holdings announced a significant rise in the value of a major contract on Tuesday.
Haydale enters collaboration with Petronas subsidiary
Haydale announced a new partnership on Tuesday with Petronas Technology Ventures (PTVSB), the technology commercialisation subsidiary of Malaysia’s state energy firm Petronas, aimed at harnessing the potential of graphene for a number of product applications.
Mirriad losses narrow as it works to bring down cash burn
In-content advertising specialist Mirriad reported first-half revenue of £0. 59m on Tuesday, making for a modest increase from the prior year's £0. 58m.
Team17 announces new chair as Chris Bell steps down
Video games label Team17 announced a change in leadership on Tuesday, with Chris Bell, who had been with the company since its initial public offering in 2018 as its non-executive chair, to step down from his position by the end of the year.
Arm files for US initial public offering
SoftBank’s Arm Holdings announced the public filing of a registration statement with the US Securities and Exchange Commission (SEC) overnight, for its proposed initial public offering.
CMA clears Broadcom's $69bn acquisition of VMware
Broadcom’s $69bn acquisition of VMware was given the nod by UK regulators on Monday, as the Competition and Markets Authority (CMA) issued its final decision after an intensive phase two investigation into the deal.
Audioboom ranked fifth by two US podcast industry analysts
Podcast producer and distributor Audioboom announced on Monday that it was emerging as the fifth largest podcast publisher in the US, according to two industry evaluations.
Fusion Antibodies progresses AI antibody collaboration
Preclinical antibody discovery specialist Fusion Antibodies updated the market on its ‘AI/ML-Ab’, or AIM-Lab, service on Monday.
Renalytix gets KidneyIntelX included in major clinical guidelines
Renalytix announced on Monday that its signature solution ‘KidneyIntelX’ has secured a spot in the draft Kidney Disease Improving Global Outcomes (KDIGO) 2023 clinical practice guideline for the evaluation and management of chronic kidney disease.
Hutchmed meets all endpoints in platelet disorder treatment trial
Hutchmed China reported a breakthrough from its recent phase three trial in sovleplenib on Monday, reporting that it met its primary endpoint and all secondary endpoints for treating adult patients with primary immune thrombocytopenia - a platelet disorder - (ITP) in China.
Agronomics investee CellX opens China cultivated meat plant
Cellular agriculture investor Agronomics announced on Thursday that its Shanghai-based investee CellX had opened a pioneering cultivated meat pilot factory in China.
Aptamer secures two contracts with big pharma firm
Life sciences company Aptamer Group has secured two new contracts with one of the world’s top five pharmaceutical companies, it announced on Thursday, with an estimated worth of up to £0. 22m.
Tremor shares tumble as adjusted earnings slide
Video and connected television (CTV) advertising technology specialist Tremor International reported a second quarter contribution excluding traffic acquisition costs (ex-TAC) of $80. 2m in its interim results on Thursday - a 13% rise from $70. 8m in the same period last year.
Kin and Carta operating profit tops market expectations
Digital entertainment consultancy Kin and Carta reported net revenue of £48m in its fourth quarter in a trading update on Thursday - a figure that fell squarely in the middle of its projected range for the period.
Belluscura receives 6,500 orders for new oxygen concentrator
Medical device developer Belluscura announced on Wednesday that it had received purchase orders for more than 6,500 units of its next-generation ‘DISCOV-R’ portable oxygen concentrator.
Gattaca upbeat amid struggles in permanent recruitment
Specialist staffing firm Gattaca reported a slight dip in continuing full-year net fee income in a trading update on Wednesday, with expected figures of £43. 6m, compared to the previous year’s £44. 1m, for a 1% year-on-year decline.